Rifampin for 4 months preferred to isoniazid for 9 months for latent TB in high-risk patients

Rifampin for 4 months preferred to isoniazid for 9 months for latent TB in high-risk patients is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central